RVB Translational Medicine Book

“The main problem is an increased gap between the amount
of data that we generate in research and the ability to apply
it into clinical practice, in a meaningful and impactful way.”
Salvatore Albani
Director of Translational Immunology Institute, Professor, Duke-NUS Graduate Medical School
Singapore, Co-founder of the Eureka Institute for Translational Medicine
“With our broad scope, we try to cover the whole
gradient of Translational Medicine, ranging from
molecular biology to new products. This is very rare to
find. The course offered by Eureka differs from most
programs because of the international setting, and the
way it is adapted to promote critical thinking and
create awareness.” Most of all, Salvatore Albani wants
to emphasize that Eureka is more than a program.
“It establishes collaborations, it creates an international
network. One could talk about the individual
achievements, but Eureka is all about a group quest.
In my opinion, the main problem in the medical world
is an increased gap between the amount of data that
we generate in research and the ability to apply it into
clinical practice, in a meaningful and impactful way,”
Salvatore explains. That is the reason why Salvatore
and his colleagues founded the Eureka Institute: “to
contribute to the growth of Translational Medicine in
a way that is directly impactful to patients.”
www.eurekainstitute.org
UMC Utrecht 11